A similar pattern of DFS was observed in TNBC patients and those with a higher frequency of CD44-/CD24- cells had a high risk to develop progressive metastasis at 4 years post tumor resection regardless of chemotherapy (Figure 2E). This evidence concerns the gene CD44 and neoplasm.